A.R.C. Laser GmbH develops and manufactures laser-based solutions for gentle and effective operations and treatments, ranging from highly complex ophthalmic procedures to nail fungus treatment. The company attributes its position as one of the strongest laser companies worldwide to its innovations and operates production at the Nuremberg site. Since July 2024 A.R.C. Laser GmbH has legally belonged to MedTech Laser Group GmbH, which acts as a holding and, alongside A.R.C., is the parent of G.N.S. neoLaser Ltd. in Israel. In the 2024 fiscal year the company employed an average of 92 employees; revenues amounted to 17,548 TEUR and net profit to 2,049 TEUR.
die Entwicklung und der Vertrieb von Lasergeräten
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Nürnberg Local Court, HRB 22103 (as of 2 November 2026)
| Name | Type | City |
|---|---|---|
| Angela Thyzel | Geschäftsführer(in) | Heroldsberg |
Source: German Commercial Register (Handelsregister) Nürnberg Local Court, HRB 22103 (as of 2 November 2026)
| Date | Event Type | Event |
|---|---|---|
| 26.02.2010 | Business Address Registered | Bessemerstraße 14, 90411 Nürnberg |
| 08.05.2008 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| 06.10.2005 | Company Name Registered | A.R.C. Laser GmbH |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 06.10.2005 | Share Capital Set | — | 150.000 € |
Source: German Commercial Register (Handelsregister) Nürnberg Local Court, HRB 22103 (as of 2 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | €17,547,800 | €2,059,045 | €9,723,451 | — |
| 2023 | €17,119,168 | €1,854,830 | €9,426,659 | — |
| 2022 | Rohergebnis€8.5M2 | €1,248,160 | €9,597,905 | — |
| 2021 | Rohergebnis€8.5M2 | €1,501,497 | €8,361,779 | — |
| 2020 | Rohergebnis€6.5M2 | €343,033 | €6,564,552 | — |
| 2019 | Rohergebnis€6.7M2 | €357,812 | €5,908,577 | — |
| 2018 | Rohergebnis€6.7M2 | €358,303 | €5,491,204 | — |
| 2017 | Rohergebnis€6.5M2 | €161,965 | €5,034,928 | — |
| 2016 | — | €264,880 | €5,046,346 | — |
| 2015 | — | €233,598 | €4,928,208 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Nürnberg Local Court, HRB 22103 (as of 2 November 2026)
MeVis Medical Solutions AG
Bremen · Entwicklung und Programmierung von Anwendungssoftware
Eckert & Ziegler Eurotope GmbH
Berlin · Herstellung von allen anderen Maschinen für sonstige bestimmte Wirtschaftszweige a. n. g.
Honeywell Healthcare Solutions GmbH
Wismar · Herstellung von elektrischen Mess-, Kontroll-, Navigations- u. ä. Instrumenten und Vorrichtungen
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €5,421,992 | 40.2% |
| Material Costs | €7,845,410 | 58.2% |
| Depreciation | €207,237 | 1.5% |
| Interest & Similar | €15,024 | 0.1% |
